cgh-array Search Results


bac-arrays igv7 (5878 bacs)  (Integragen sa)
90
Integragen sa bac-arrays igv7 (5878 bacs)
Bac Arrays Igv7 (5878 Bacs), supplied by Integragen sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bac-arrays igv7 (5878 bacs)/product/Integragen sa
Average 90 stars, based on 1 article reviews
bac-arrays igv7 (5878 bacs) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
array-comparative genomic hybridization analysis  (Oxford Gene Technology)
90
Oxford Gene Technology array-comparative genomic hybridization analysis
Array Comparative Genomic Hybridization Analysis, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array-comparative genomic hybridization analysis/product/Oxford Gene Technology
Average 90 stars, based on 1 article reviews
array-comparative genomic hybridization analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
karyotyping cgh array karyotyping service  (Nihon Gene Research Laboratories)
90
Nihon Gene Research Laboratories karyotyping cgh array karyotyping service
Karyotyping Cgh Array Karyotyping Service, supplied by Nihon Gene Research Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/karyotyping cgh array karyotyping service/product/Nihon Gene Research Laboratories
Average 90 stars, based on 1 article reviews
karyotyping cgh array karyotyping service - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
human whole-genome cgh array system cgar0150-whg8cgh array 7  (NimbleGen Systems GmbH)
90
NimbleGen Systems GmbH human whole-genome cgh array system cgar0150-whg8cgh array 7
Human Whole Genome Cgh Array System Cgar0150 Whg8cgh Array 7, supplied by NimbleGen Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human whole-genome cgh array system cgar0150-whg8cgh array 7/product/NimbleGen Systems GmbH
Average 90 stars, based on 1 article reviews
human whole-genome cgh array system cgar0150-whg8cgh array 7 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
genomic tiling arrays nimblegen systems  (NimbleGen Systems GmbH)
90
NimbleGen Systems GmbH genomic tiling arrays nimblegen systems
Genomic Tiling Arrays Nimblegen Systems, supplied by NimbleGen Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genomic tiling arrays nimblegen systems/product/NimbleGen Systems GmbH
Average 90 stars, based on 1 article reviews
genomic tiling arrays nimblegen systems - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cgh array p3  (Promega)
90
Promega cgh array p3
CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial <t>P3</t> GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests
Cgh Array P3, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgh array p3/product/Promega
Average 90 stars, based on 1 article reviews
cgh array p3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
comparative genome hybridization (cgh) array (400k)  (Bioarray Inc)
90
Bioarray Inc comparative genome hybridization (cgh) array (400k)
CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial <t>P3</t> GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests
Comparative Genome Hybridization (Cgh) Array (400k), supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/comparative genome hybridization (cgh) array (400k)/product/Bioarray Inc
Average 90 stars, based on 1 article reviews
comparative genome hybridization (cgh) array (400k) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cgh array  (NextGen Sciences)
90
NextGen Sciences cgh array
CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial <t>P3</t> GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests
Cgh Array, supplied by NextGen Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgh array/product/NextGen Sciences
Average 90 stars, based on 1 article reviews
cgh array - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
copy number (dosage) analysis using comparative genomic hybridisation (cgh) array  (Labplus Inc)
90
Labplus Inc copy number (dosage) analysis using comparative genomic hybridisation (cgh) array
CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial <t>P3</t> GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests
Copy Number (Dosage) Analysis Using Comparative Genomic Hybridisation (Cgh) Array, supplied by Labplus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/copy number (dosage) analysis using comparative genomic hybridisation (cgh) array/product/Labplus Inc
Average 90 stars, based on 1 article reviews
copy number (dosage) analysis using comparative genomic hybridisation (cgh) array - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cgh array  (Broad Institute Inc)
90
Broad Institute Inc cgh array
CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial <t>P3</t> GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests
Cgh Array, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgh array/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
cgh array - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
2×105k genome-wide oligonucleotide array-cgh (array-based comparative genomic hybridization)  (BlueGnome Limited)
90
BlueGnome Limited 2×105k genome-wide oligonucleotide array-cgh (array-based comparative genomic hybridization)
CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial <t>P3</t> GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests
2×105k Genome Wide Oligonucleotide Array Cgh (Array Based Comparative Genomic Hybridization), supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2×105k genome-wide oligonucleotide array-cgh (array-based comparative genomic hybridization)/product/BlueGnome Limited
Average 90 stars, based on 1 article reviews
2×105k genome-wide oligonucleotide array-cgh (array-based comparative genomic hybridization) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
exon-level cgh-array targeting neuromuscular disorder genes  (GeneDx Inc)
90
GeneDx Inc exon-level cgh-array targeting neuromuscular disorder genes
CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial <t>P3</t> GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests
Exon Level Cgh Array Targeting Neuromuscular Disorder Genes, supplied by GeneDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exon-level cgh-array targeting neuromuscular disorder genes/product/GeneDx Inc
Average 90 stars, based on 1 article reviews
exon-level cgh-array targeting neuromuscular disorder genes - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial P3 GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests

Journal: Nature Communications

Article Title: The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors

doi: 10.1038/s41467-017-01686-y

Figure Lengend Snippet: CXCR3 and LRP1 expression in glioblastoma samples from patients. a HE staining was performed in the experimental mouse intracranial P3 GBM model that recapitulates the regional heterogeneity of gliomas. (1) healthy brain, (2) angiogenic part, and (3) invasive part. b Immunofluorescence with anti-vimentin (sc-6260 clone V9, Santa Cruz) ( λ = 547 nm) and anti-LRP1 (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) antibodies on tissue from healthy mouse brain, angiogenic, or invasive part of the P3 GBM tumor. Scale: 5 µm. c Graph depicts the quantification of LRP1 expression in angiogenic and invasive areas ( n = 30). *** P <0.001. d MRI image from a representative glioblastoma (GBM) patient. Samples were taken intraoperatively with the aid of neuronavigation from the tumor angiogenic core (contrast enhancement ring) and the infiltrative area (T1 hypointense abnormality). e Immunofluorescence with anti-CXCR3 (antibody 2ar1, Abcam) and anti-LRP1 antibodies (antibody 2703-1 for LRP1β, Epitomics) ( λ = 488 nm) on tissue samples from either the angiogenic or invasive part of the tumor. Membrane and/or perinuclear localization of CXCR3 and LRP1 were observed at a ×630 magnification with phase contrast brightfield under a confocal laser scanning microscope (Nikon Eclipse ti). Scale: 5 μm. Graphs (protein intensity, n = 30, and CXCR3 localization, n > 300) depict the quantification from three different patients. NS non-significant. *** P <0.001. Statistical comparison between two groups was performed using the Mann–Whitney U -test. Multiple comparisons were performed with one-way analysis of variance, followed by Bonferroni post hoc tests

Article Snippet: All cells used for phenotypic and functional studies have been further characterized more in detail by cGH array (P3) and by cell authentification using Promega Powerplex21 Kit (Eurofins, GE) (cell lines).

Techniques: Expressing, Staining, Immunofluorescence, Membrane, Laser-Scanning Microscopy, Comparison, MANN-WHITNEY